| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 67 | 2019 | 653 | 6.740 |
Why?
|
| Genetic Vectors | 39 | 2019 | 809 | 3.930 |
Why?
|
| Genetic Therapy | 20 | 2019 | 734 | 2.010 |
Why?
|
| Viral Proteins | 22 | 2009 | 256 | 1.760 |
Why?
|
| Baculoviridae | 8 | 2013 | 26 | 1.290 |
Why?
|
| DNA-Binding Proteins | 20 | 2004 | 1151 | 1.250 |
Why?
|
| Transduction, Genetic | 20 | 2016 | 228 | 1.200 |
Why?
|
| Recombination, Genetic | 18 | 2008 | 239 | 1.100 |
Why?
|
| DNA, Viral | 17 | 2011 | 223 | 1.030 |
Why?
|
| Gene Transfer Techniques | 16 | 2016 | 304 | 0.970 |
Why?
|
| Bioreactors | 5 | 2011 | 34 | 0.850 |
Why?
|
| Insecta | 6 | 2011 | 37 | 0.680 |
Why?
|
| Virus Replication | 6 | 2013 | 305 | 0.670 |
Why?
|
| Invertebrates | 2 | 2017 | 21 | 0.640 |
Why?
|
| Animals | 53 | 2022 | 19677 | 0.630 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2005 | 90 | 0.600 |
Why?
|
| Molecular Sequence Data | 24 | 2012 | 1953 | 0.600 |
Why?
|
| Dystrophin | 3 | 2014 | 31 | 0.590 |
Why?
|
| Muscular Dystrophy, Duchenne | 3 | 2014 | 39 | 0.570 |
Why?
|
| Genome, Viral | 6 | 2013 | 122 | 0.550 |
Why?
|
| Cell Line | 18 | 2017 | 1984 | 0.550 |
Why?
|
| Cloning, Molecular | 11 | 2008 | 381 | 0.540 |
Why?
|
| RNA, Small Nuclear | 2 | 2014 | 25 | 0.500 |
Why?
|
| Transfection | 3 | 2013 | 675 | 0.490 |
Why?
|
| Blotting, Western | 8 | 2012 | 584 | 0.470 |
Why?
|
| DNA, Recombinant | 2 | 2013 | 44 | 0.450 |
Why?
|
| Base Sequence | 20 | 2012 | 1302 | 0.430 |
Why?
|
| Virus Integration | 5 | 1996 | 32 | 0.400 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2005 | 46 | 0.370 |
Why?
|
| DNA | 5 | 2013 | 806 | 0.370 |
Why?
|
| Gene Expression | 9 | 2016 | 810 | 0.350 |
Why?
|
| Plasmids | 6 | 2005 | 279 | 0.350 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2008 | 25 | 0.340 |
Why?
|
| Chromatography, Gel | 2 | 2008 | 65 | 0.340 |
Why?
|
| DNA Replication | 8 | 2011 | 230 | 0.330 |
Why?
|
| Adenoviridae | 4 | 2007 | 117 | 0.320 |
Why?
|
| Genetic Techniques | 1 | 2009 | 39 | 0.320 |
Why?
|
| Bocavirus | 1 | 2009 | 2 | 0.320 |
Why?
|
| Parvoviridae Infections | 1 | 2009 | 23 | 0.310 |
Why?
|
| Humans | 50 | 2019 | 59479 | 0.310 |
Why?
|
| Virus Cultivation | 2 | 2007 | 18 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 19 | 6 | 1995 | 17 | 0.290 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 292 | 0.280 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 750 | 0.280 |
Why?
|
| Biotechnology | 1 | 2007 | 42 | 0.280 |
Why?
|
| Spodoptera | 4 | 2013 | 27 | 0.280 |
Why?
|
| Molecular Biology | 1 | 2008 | 66 | 0.270 |
Why?
|
| Amino Acid Sequence | 9 | 2009 | 1555 | 0.270 |
Why?
|
| Transgenes | 3 | 2016 | 177 | 0.270 |
Why?
|
| Capsid Proteins | 3 | 2016 | 92 | 0.260 |
Why?
|
| Recombinant Proteins | 9 | 2008 | 691 | 0.250 |
Why?
|
| Bisbenzimidazole | 1 | 2005 | 3 | 0.240 |
Why?
|
| Genes, Viral | 2 | 1998 | 56 | 0.230 |
Why?
|
| Benzimidazoles | 1 | 2005 | 54 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 2057 | 0.230 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 156 | 0.230 |
Why?
|
| HeLa Cells | 9 | 1999 | 526 | 0.210 |
Why?
|
| Replication Origin | 2 | 2002 | 36 | 0.210 |
Why?
|
| Sf9 Cells | 2 | 2013 | 7 | 0.210 |
Why?
|
| Green Fluorescent Proteins | 9 | 2011 | 355 | 0.210 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 851 | 0.210 |
Why?
|
| Parvovirus | 1 | 2022 | 24 | 0.200 |
Why?
|
| Glucose | 2 | 2008 | 444 | 0.200 |
Why?
|
| Transposases | 1 | 2002 | 14 | 0.200 |
Why?
|
| Vertebrates | 1 | 2022 | 41 | 0.200 |
Why?
|
| Nucleic Acid Conformation | 9 | 2002 | 234 | 0.200 |
Why?
|
| Densovirus | 1 | 2002 | 1 | 0.190 |
Why?
|
| Mice | 16 | 2016 | 10308 | 0.190 |
Why?
|
| COS Cells | 6 | 2003 | 174 | 0.190 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 858 | 0.190 |
Why?
|
| DNA Helicases | 3 | 1998 | 188 | 0.180 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2002 | 93 | 0.180 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 1994 | 43 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 1994 | 36 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 328 | 0.160 |
Why?
|
| Quality Control | 1 | 2019 | 71 | 0.160 |
Why?
|
| Genetic Engineering | 2 | 2013 | 111 | 0.160 |
Why?
|
| Caspases | 1 | 2000 | 166 | 0.160 |
Why?
|
| Terminal Repeat Sequences | 1 | 1999 | 13 | 0.160 |
Why?
|
| Commerce | 1 | 2019 | 53 | 0.160 |
Why?
|
| Dogs | 4 | 2014 | 316 | 0.160 |
Why?
|
| DNA, Single-Stranded | 1 | 2000 | 100 | 0.160 |
Why?
|
| Trans-Activators | 2 | 1998 | 300 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2009 | 178 | 0.150 |
Why?
|
| Islets of Langerhans | 1 | 2000 | 271 | 0.150 |
Why?
|
| Antigens, CD | 3 | 1998 | 343 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 6 | 2003 | 652 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 289 | 0.150 |
Why?
|
| Central Nervous System | 2 | 2016 | 194 | 0.150 |
Why?
|
| Retina | 3 | 2003 | 115 | 0.150 |
Why?
|
| Protein Kinases | 1 | 1998 | 142 | 0.140 |
Why?
|
| Exons | 3 | 2014 | 191 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 6 | 1999 | 490 | 0.140 |
Why?
|
| Escherichia coli Proteins | 3 | 1994 | 264 | 0.140 |
Why?
|
| Rabbits | 3 | 2009 | 326 | 0.140 |
Why?
|
| Rats | 9 | 2007 | 1909 | 0.140 |
Why?
|
| Neoplasms | 1 | 2007 | 1233 | 0.130 |
Why?
|
| Carrier Proteins | 5 | 2012 | 697 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 1998 | 661 | 0.130 |
Why?
|
| Binding Sites | 7 | 2004 | 881 | 0.130 |
Why?
|
| Marsupialia | 1 | 2016 | 5 | 0.130 |
Why?
|
| Fossils | 1 | 2016 | 7 | 0.130 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 43 | 0.130 |
Why?
|
| Viral Tropism | 1 | 2016 | 50 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 97 | 0.120 |
Why?
|
| Apoptosis | 1 | 2000 | 1033 | 0.120 |
Why?
|
| Muscles | 1 | 2016 | 173 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 529 | 0.120 |
Why?
|
| Lymphocytes | 1 | 1995 | 191 | 0.120 |
Why?
|
| Forelimb | 1 | 2014 | 9 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2008 | 190 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 496 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 2054 | 0.110 |
Why?
|
| Endonucleases | 3 | 2011 | 80 | 0.110 |
Why?
|
| Spectrum Analysis | 2 | 2007 | 51 | 0.110 |
Why?
|
| Substrate Specificity | 4 | 2004 | 333 | 0.110 |
Why?
|
| Myocardium | 2 | 2012 | 264 | 0.110 |
Why?
|
| Insect Vectors | 1 | 2013 | 14 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2002 | 841 | 0.100 |
Why?
|
| Brain | 4 | 2007 | 1493 | 0.100 |
Why?
|
| Cricetinae | 3 | 2000 | 366 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 418 | 0.100 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 223 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1997 | 75 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 133 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2002 | 255 | 0.090 |
Why?
|
| Capsid | 3 | 2002 | 88 | 0.090 |
Why?
|
| Virology | 1 | 2011 | 13 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 356 | 0.090 |
Why?
|
| RNA Interference | 2 | 2005 | 590 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 127 | 0.090 |
Why?
|
| Insulin | 2 | 2008 | 672 | 0.090 |
Why?
|
| Male | 9 | 2013 | 27794 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 122 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2012 | 187 | 0.090 |
Why?
|
| Luminescent Proteins | 4 | 2003 | 128 | 0.090 |
Why?
|
| Antigens, Viral | 2 | 2009 | 130 | 0.090 |
Why?
|
| Haplorhini | 2 | 2002 | 14 | 0.090 |
Why?
|
| Salivary Glands | 2 | 2002 | 46 | 0.090 |
Why?
|
| RNA, Ribosomal | 3 | 1986 | 53 | 0.080 |
Why?
|
| Virion | 2 | 2003 | 119 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 178 | 0.080 |
Why?
|
| Genome, Human | 1 | 2011 | 225 | 0.080 |
Why?
|
| Protein Binding | 5 | 2012 | 1555 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 48 | 0.080 |
Why?
|
| Virosomes | 1 | 2009 | 5 | 0.080 |
Why?
|
| Serum | 1 | 2009 | 28 | 0.080 |
Why?
|
| Seroepidemiologic Studies | 1 | 2009 | 48 | 0.080 |
Why?
|
| Time Factors | 3 | 2013 | 3619 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2009 | 184 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 133 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 461 | 0.080 |
Why?
|
| Simplexvirus | 1 | 2008 | 25 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 1368 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 248 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2004 | 2095 | 0.070 |
Why?
|
| Industry | 1 | 2008 | 59 | 0.070 |
Why?
|
| Ultracentrifugation | 1 | 2008 | 28 | 0.070 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1987 | 11 | 0.070 |
Why?
|
| Biomass | 1 | 2008 | 25 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 446 | 0.070 |
Why?
|
| Blotting, Southern | 2 | 2002 | 52 | 0.070 |
Why?
|
| Oxides | 1 | 2007 | 33 | 0.070 |
Why?
|
| Catalysis | 2 | 2000 | 152 | 0.070 |
Why?
|
| DNA Probes | 3 | 1994 | 35 | 0.070 |
Why?
|
| Serotyping | 3 | 2006 | 50 | 0.070 |
Why?
|
| Kinetochores | 1 | 2007 | 26 | 0.070 |
Why?
|
| DNA, Mitochondrial | 2 | 1984 | 76 | 0.070 |
Why?
|
| Iron | 1 | 2007 | 136 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 75 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1561 | 0.070 |
Why?
|
| Glioblastoma | 2 | 2006 | 155 | 0.070 |
Why?
|
| Kinetics | 3 | 2002 | 751 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2007 | 259 | 0.070 |
Why?
|
| B7-1 Antigen | 2 | 1997 | 73 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 165 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 298 | 0.070 |
Why?
|
| TATA Box | 2 | 1999 | 11 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1997 | 111 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1469 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2007 | 293 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 196 | 0.060 |
Why?
|
| Glioma | 1 | 2006 | 99 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2007 | 162 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 394 | 0.060 |
Why?
|
| Fetal Development | 1 | 2005 | 16 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2007 | 645 | 0.060 |
Why?
|
| Contrast Media | 1 | 2007 | 405 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2005 | 183 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2005 | 1554 | 0.060 |
Why?
|
| Epithelial Cells | 4 | 2002 | 390 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2005 | 112 | 0.060 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2004 | 10 | 0.060 |
Why?
|
| Restriction Mapping | 2 | 1997 | 51 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 10 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 70 | 0.060 |
Why?
|
| Luciferases | 2 | 2002 | 106 | 0.050 |
Why?
|
| Liver | 1 | 2008 | 796 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2012 | 3240 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2005 | 146 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2005 | 383 | 0.050 |
Why?
|
| Acclimatization | 1 | 2022 | 10 | 0.050 |
Why?
|
| Cesium | 1 | 2002 | 6 | 0.050 |
Why?
|
| Ecology | 1 | 2022 | 12 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2002 | 35 | 0.050 |
Why?
|
| Agriculture | 1 | 2022 | 30 | 0.050 |
Why?
|
| Chlorides | 1 | 2002 | 32 | 0.050 |
Why?
|
| B7-2 Antigen | 3 | 1998 | 32 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2002 | 206 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2002 | 81 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 302 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2016 | 241 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 209 | 0.050 |
Why?
|
| Female | 4 | 2012 | 30779 | 0.050 |
Why?
|
| Heparin | 1 | 2002 | 111 | 0.050 |
Why?
|
| Kidney | 2 | 2002 | 414 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2002 | 149 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 284 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2000 | 25 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2016 | 1128 | 0.040 |
Why?
|
| G1 Phase | 1 | 2000 | 55 | 0.040 |
Why?
|
| Maltose-Binding Proteins | 3 | 1994 | 4 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 103 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2000 | 54 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 359 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 805 | 0.040 |
Why?
|
| Phosphorylation | 2 | 1999 | 884 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 4277 | 0.040 |
Why?
|
| Aquaporins | 1 | 1998 | 6 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 450 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 46 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2000 | 253 | 0.040 |
Why?
|
| DNA Damage | 1 | 2000 | 279 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2000 | 526 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2006 | 656 | 0.040 |
Why?
|
| Adolescent | 1 | 2009 | 5854 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 1998 | 45 | 0.040 |
Why?
|
| Hemagglutination Tests | 1 | 1997 | 3 | 0.040 |
Why?
|
| beta-Galactosidase | 3 | 2005 | 77 | 0.040 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1997 | 4 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1997 | 108 | 0.040 |
Why?
|
| Mutation | 2 | 2011 | 2458 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 160 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1995 | 35 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 146 | 0.030 |
Why?
|
| Genes | 3 | 1986 | 90 | 0.030 |
Why?
|
| Rats, Nude | 2 | 2006 | 25 | 0.030 |
Why?
|
| United States | 1 | 2009 | 7431 | 0.030 |
Why?
|
| Spheroids, Cellular | 2 | 2006 | 26 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 29 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 2007 | 46 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 190 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 171 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 289 | 0.030 |
Why?
|
| Genes, ras | 1 | 1994 | 27 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 334 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 163 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 298 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 1994 | 30 | 0.030 |
Why?
|
| Aged | 1 | 2009 | 13426 | 0.030 |
Why?
|
| Photoreceptor Cells | 2 | 2003 | 20 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 763 | 0.030 |
Why?
|
| Macaca | 1 | 2012 | 29 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 1997 | 325 | 0.020 |
Why?
|
| Adult | 1 | 2009 | 15704 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 16342 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 29 | 0.020 |
Why?
|
| Rats, Wistar | 2 | 2002 | 179 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1989 | 99 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 329 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2011 | 96 | 0.020 |
Why?
|
| Fibrosis | 1 | 2011 | 154 | 0.020 |
Why?
|
| Submandibular Gland | 2 | 2002 | 5 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2003 | 226 | 0.020 |
Why?
|
| Lysogeny | 1 | 1990 | 5 | 0.020 |
Why?
|
| KB Cells | 1 | 1990 | 15 | 0.020 |
Why?
|
| Clone Cells | 1 | 1990 | 106 | 0.020 |
Why?
|
| Proviruses | 1 | 1990 | 26 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 619 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 1990 | 53 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1994 | 695 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 458 | 0.020 |
Why?
|
| Bucladesine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 9 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1994 | 738 | 0.020 |
Why?
|
| Imines | 1 | 2008 | 4 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2008 | 6 | 0.020 |
Why?
|
| Streptozocin | 1 | 2008 | 21 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2377 | 0.020 |
Why?
|
| Methanol | 1 | 1987 | 13 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2002 | 365 | 0.020 |
Why?
|
| Freezing | 1 | 1987 | 18 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1987 | 67 | 0.020 |
Why?
|
| Cytidine Monophosphate | 1 | 1987 | 12 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2007 | 17 | 0.020 |
Why?
|
| Convection | 1 | 2007 | 10 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2007 | 21 | 0.020 |
Why?
|
| Crystallization | 1 | 1987 | 97 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 45 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2007 | 28 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1987 | 191 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2007 | 106 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 26 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 161 | 0.020 |
Why?
|
| Nucleic Acid Precursors | 1 | 1986 | 2 | 0.020 |
Why?
|
| Cycloleucine | 1 | 1986 | 6 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 574 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 46 | 0.020 |
Why?
|
| Particle Size | 1 | 2007 | 395 | 0.020 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2006 | 44 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2005 | 47 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 180 | 0.010 |
Why?
|
| Aedes | 1 | 1984 | 12 | 0.010 |
Why?
|
| Amino Acids | 1 | 1986 | 140 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Ethanol | 1 | 1987 | 309 | 0.010 |
Why?
|
| Ataxins | 1 | 2004 | 5 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2004 | 5 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 148 | 0.010 |
Why?
|
| Huntingtin Protein | 1 | 2005 | 138 | 0.010 |
Why?
|
| Glutamine | 1 | 2004 | 46 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 18 | 0.010 |
Why?
|
| Electroretinography | 1 | 2003 | 26 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 133 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 651 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2003 | 88 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 133 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 103 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 90 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 228 | 0.010 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2002 | 22 | 0.010 |
Why?
|
| Calorimetry | 1 | 2002 | 40 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 378 | 0.010 |
Why?
|
| Mitochondria | 1 | 1986 | 343 | 0.010 |
Why?
|
| Injections | 1 | 2002 | 76 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2002 | 118 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 333 | 0.010 |
Why?
|
| Tail | 1 | 2002 | 6 | 0.010 |
Why?
|
| Bacillus | 1 | 2002 | 13 | 0.010 |
Why?
|
| Static Electricity | 1 | 2002 | 163 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 424 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1206 | 0.010 |
Why?
|
| Protein Folding | 1 | 2002 | 260 | 0.010 |
Why?
|
| Methylation | 2 | 1994 | 125 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 868 | 0.010 |
Why?
|
| Bronchi | 1 | 2000 | 82 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 1999 | 1 | 0.010 |
Why?
|
| Aquaporin 1 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Microinjections | 1 | 1999 | 67 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1998 | 6 | 0.010 |
Why?
|
| X Chromosome | 1 | 1999 | 44 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 39 | 0.010 |
Why?
|
| HT29 Cells | 1 | 1998 | 28 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1999 | 142 | 0.010 |
Why?
|
| X-Rays | 1 | 1998 | 45 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 1999 | 193 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1997 | 3 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 48 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1998 | 130 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 347 | 0.010 |
Why?
|
| Water | 1 | 1998 | 300 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1997 | 164 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 1999 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1997 | 170 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1997 | 354 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1997 | 228 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 743 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 25 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 318 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1994 | 98 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 473 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 243 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1988 | 17 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1994 | 1471 | 0.000 |
Why?
|
| RNA Precursors | 1 | 1986 | 74 | 0.000 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1984 | 5 | 0.000 |
Why?
|